echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Anti-Influenza Class 1 New Drug ADC189 Approved Clinically in China

    Anti-Influenza Class 1 New Drug ADC189 Approved Clinically in China

    • Last Update: 2021-09-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Text|Pharmaceutical Mission Hills

    Recently, Antikang Biotechnology announced that the company's independent research and development of the company's independent research and development of the new drug ADC189 for the treatment and prevention of influenza A and B has been approved by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration.


    Screenshot source: CDE official website

    It is reported that ADC189 has a new anti-influenza mechanism that can directly inhibit virus replication


    Antikang Bio's design and development of ADC189 aims to combat influenza A and B viruses, including influenza strains resistant to oseltamivir and avian influenza strains (H7N9, H5N1)


    It is worth mentioning that a single oral dose of this new drug under development can block influenza virus replication within 24 hours


    Public information shows that the Antikang bioscientist team has long focused on the research and development of small molecule innovative drugs in the field of anti-infection


    According to Dr.


    Reference materials:

    [1] Center for Drug Evaluation (CDE) of China National Medical Products Administration.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.